Recurrent cervical carcinoma after radical hysterectomy.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 3391421)

Published in Gynecol Oncol on July 01, 1988

Authors

D M Larson1, L J Copeland, C A Stringer, D M Gershenson, J M Malone, C L Edwards

Author Affiliations

1: Department of Gynecology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston.

Articles citing this

Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT. Eur J Nucl Med Mol Imaging (2008) 1.12

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial. J Transl Med (2013) 1.02

Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer. Eur Radiol (2008) 0.90

Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma. Eur J Nucl Med Mol Imaging (2009) 0.89

Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT studies for the diagnosis of uterine cancer recurrence. Eur J Nucl Med Mol Imaging (2010) 0.84

Intraoperative Electron Beam Radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer. Radiat Oncol (2013) 0.79

Risk strata-based therapy and outcome in stage Ib-IIa carcinoma cervix: single-centre ten-year experience. Ecancermedicalscience (2013) 0.78

Clinical Usefulness of (18)F-FDG PET/CT in the Detection of Early Recurrence in Treated Cervical Cancer Patients with Unexplained Elevation of Serum Tumor Markers. Chonnam Med J (2013) 0.78

Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in Japan. J Gynecol Oncol (2016) 0.77

Recurrent cervical cancer isolated to the sigmoid colon: A case report. Gynecol Oncol Case Rep (2013) 0.77

3D radiation therapy or intensity-modulated radiotherapy for recurrent and metastatic cervical cancer: the Shanghai Cancer Hospital experience. PLoS One (2012) 0.77

Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer. Cancer Immunol Immunother (2016) 0.75

Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT). Radiat Oncol (2016) 0.75

Articles by these authors

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med (1999) 7.56

Systemic anticancer therapy in gynecological cancer patients with renal dysfunction. Int J Gynecol Cancer (2007) 2.71

Ovarian carcinomas with transitional cell carcinoma pattern. Am J Clin Pathol (1990) 2.70

Tumor scanning with 67Ga citrate. J Nucl Med (1969) 2.18

Reliability and validity of the functional assessment of cancer therapy-ovarian. J Clin Oncol (2001) 2.05

Didelphic uterus and obstructed hemivagina with renal agenesis: case report and review of the literature. J Pediatr Adolesc Gynecol (2004) 2.01

Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol (2000) 1.95

Paget's disease of the vulva: pathology, pattern of involvement, and prognosis. Gynecol Oncol (2000) 1.82

Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. J Clin Oncol (2001) 1.73

Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies. Gynecol Oncol (2001) 1.59

Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol (1999) 1.56

Primary medical management of recurrent aggressive angiomyxoma of the vulva with a gonadotropin-releasing hormone agonist. Gynecol Oncol (2001) 1.55

Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential. Int J Gynecol Pathol (1998) 1.54

Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol (1999) 1.53

Prognostic factors in adult granulosa cell tumor of the ovary. Cancer (1997) 1.49

Ureteroinguinal hernia: a rare companion of sliding inguinal hernias. Am Surg (1991) 1.48

Extramammary Paget's disease of the perineal skin: role of radiotherapy. Int J Radiat Oncol Biol Phys (1992) 1.44

Groin dissection practices among gynecologic oncologists treating early vulvar cancer. Gynecol Oncol (1996) 1.43

Extensive subcutaneous metastases from squamous cell carcinoma of the cervix in patient with HIV. Int J Gynecol Cancer (2001) 1.42

The natural history of bilateral aortofemoral bypass grafts for ischemia of the lower extremities. Arch Surg (1975) 1.35

Papillary serous carcinoma of the peritoneum. Obstet Gynecol (1990) 1.33

Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol (1996) 1.33

Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom Med (2001) 1.31

67Ga-citrate imaging in untreated Hodgkin's disease: preliminary report of Cooperative Group. J Nucl Med (1974) 1.28

Clear cell carcinoma of the ovary: a study of 59 cases. Gynecol Oncol (1989) 1.24

Sexual self-schema and sexual morbidity among gynecologic cancer survivors. J Consult Clin Psychol (1997) 1.24

Melphalan may be a more potent leukemogen than cyclophosphamide. Ann Intern Med (1986) 1.23

Scanning malignant neoplasms with gallium 67. JAMA (1970) 1.23

Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys (2003) 1.20

Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol (1994) 1.18

Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol (2001) 1.17

Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol (1990) 1.16

Differential effects of fat and sucrose on body composition in A/J and C57BL/6 mice. Metabolism (1998) 1.14

Endometrial papillary serous carcinoma: patterns of spread and treatment. Clin Obstet Gynecol (1996) 1.14

Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites. Cancer Res (1991) 1.12

Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J Immunol Methods (1994) 1.11

Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res (2001) 1.11

Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer. Gynecol Oncol (1997) 1.11

Inflammatory aneurysms of the abdominal aorta. Surgery (1978) 1.11

Natural history of nonstenotic, asymptomatic ulcerative lesions of the carotid artery. Arch Surg (1978) 1.11

Standardized histologic grading of epithelial ovarian cancer: elusive after all these years. Gynecol Oncol (1998) 1.10

Sexual dysfunction and treatment for early stage cervical cancer. Cancer (1989) 1.10

Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care (1992) 1.09

The use of medicinal leeches in the salvage of flaps with venous congestion. Ann Plast Surg (1992) 1.08

Analysis of the severe complications of irradiation of carcinoma of the cervix: whole pelvis irradiation and intracavitary radium. Int J Radiat Oncol Biol Phys (1983) 1.08

Therapeutic and economic impact of a modern amputation program. Ann Surg (1979) 1.08

Extrathoracic repair of branch occlusions of the aortic arch. Am J Surg (1976) 1.07

Sigmoid perforation following radiation therapy in patients with cervical cancer. Gynecol Oncol (2001) 1.07

Digital video subtraction angiography: screening technique for renovascular hypertension. Surgery (1981) 1.07

The biogenesis of mitochondria. IX. Formation of the soluble mitochondrial enzymes malate dehydrogenase and fumarase in Saccharomyces cerevisiae. Arch Biochem Biophys (1969) 1.07

Immature teratoma of the ovary. Obstet Gynecol (1986) 1.07

Correlation between patient weight and defects in DNA mismatch repair: is this the link between an increased risk of previous cancer in thinner women with endometrial cancer? Int J Gynecol Cancer (2007) 1.07

Mixed germ cell tumors of the ovary. Obstet Gynecol (1984) 1.06

HER-2/neu amplification and overexpression in endometrial carcinoma. Int J Gynecol Pathol (1999) 1.06

Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol (1994) 1.06

Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol (1987) 1.04

HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2. Cell Immunol (1996) 1.04

Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma. J Clin Oncol (1996) 1.04

Non-Hodgkin's lymphoma involving the vagina: a clinicopathologic analysis of 14 patients. Am J Surg Pathol (2000) 1.04

Prosthetic arterial graft material. Influence on neointimal healing and bacteremic infectibility. Arch Surg (1980) 1.02

Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol (1999) 1.02

Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor. J Reprod Med (1996) 1.02

Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum. Clin Cancer Res (1996) 1.01

A comparative study of the endometrial jet-washing technic and endometrial biopsy. Am J Clin Pathol (1972) 1.01

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecol Oncol (1992) 1.01

Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer. Ann Intern Med (2000) 1.01

Interstitial brachytherapy in the management of primary carcinoma of the cervix and vagina. Gynecol Oncol (1998) 1.01

Retrospective review: re-treatment of patients with ovarian cancer with carboplatin after platinum resistance. Int J Gynecol Cancer (2005) 1.00

Fibrinolytic treatment of residual thrombus after catheter embolectomy for severe lower limb ischemia. J Vasc Surg (1989) 0.98

Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer. Gynecol Oncol (1991) 0.98

Single-agent cis-platinum therapy for advanced ovarian cancer. Obstet Gynecol (1981) 0.98

Adenoid cystic carcinoma of Bartholin gland. Obstet Gynecol (1986) 0.98

A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix. Clin Cancer Res (1997) 0.98

Bacteremic infectability of vascular grafts: the influence of pseudointimal integrity and duration of graft function. Surgery (1975) 0.97

Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol (1990) 0.97

Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer. Gynecol Oncol (2001) 0.97

Tamoxifen therapy of epithelial ovarian cancer. Obstet Gynecol (1985) 0.97

Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer. Gynecol Oncol (2011) 0.96

Management of small artery vascular trauma. Am J Surg (1992) 0.96

Prospective randomized trial of LLETZ versus laser ablation in patients with cervical intraepithelial neoplasia. Gynecol Oncol (1994) 0.96

Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol (2000) 0.96

Complications of carotid artery replacement in head and neck neoplasms. Otolaryngol Head Neck Surg (1983) 0.96

High-risk metastatic gestational trophoblastic disease. Obstet Gynecol (1985) 0.95

Quality assurance of second opinion pathology in gynecologic oncology. Obstet Gynecol (1999) 0.95

Bacteremic infectability: a function of vascular graft material and design. J Surg Res (1977) 0.95

Distribution of gallium in human tissues after intravenous administration. J Nucl Med (1972) 0.95

Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. J Clin Oncol (1998) 0.95